Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CELANESE CORP (CE)

  • Business News
  • June 15, 2026, 13:00 UTC
  • 0
  • 1 comments

Celanese and Siegwerk Collaborate to Advance More Sustainable Printing Ink Solutions with Bio-Based Ethyl Acetate

Market reaction Comment Full text

WELLS FARGO & COMPANY/MN (WFC)

  • Business News
  • June 15, 2026, 13:00 UTC
  • 0
  • 1 comments

Wells Fargo Named as ICON Preferred Mortgage Lender to Support 3D‑Printed Homes

Market reaction Comment Full text

BLOOM ENERGY CORP (BE)

  • Business News
  • June 15, 2026, 13:00 UTC
  • 0
  • 1 comments

AI Data Center Growth Hinges on Solving Both Power Constraints and Community Concerns, Bloom Energy Report Finds

Market reaction Comment Full text

MARKEL GROUP INC. (MKL)

  • Business News
  • June 15, 2026, 13:00 UTC
  • 0
  • 1 comments

Markel Canada Strengthens Contractors, Trades and Construction Services (CTCS) Sector Leadership With Key Appointments

Market reaction Comment Full text

JPMORGAN CHASE & CO (JPM)

  • Business News
  • June 15, 2026, 13:00 UTC
  • 0
  • 1 comments

Meet the New Chase Sapphire Preferred: Earn More Than Ever, Same $95 Annual Fee

Market reaction Comment Full text

ENGENE HOLDINGS INC. (ENGN)

  • Business News
  • June 15, 2026, 13:00 UTC
  • 0
  • 1 comments

enGene Reports Second Quarter 2026 Financial Results and Provides Business Update

Market reaction Comment Full text

CLEAN ENERGY TECHNOLOGIES, INC. (CETY)

  • Business News
  • June 15, 2026, 13:00 UTC
  • 0
  • 1 comments

CETY Partnership With Sagacity Yields Success in Design and Manufacture of Advanced ORC Components, Significantly Reducing System Costs and Strengthening Supply Chain Efficiency

Market reaction Comment Full text

XBIOTECH INC. (XBIT)

  • Business News
  • June 15, 2026, 13:00 UTC
  • 0
  • 1 comments

XBiotech lance un essai clinique de phase II visant à évaluer le vilamakitug dans le traitement de la spondylarthrite axiale active

Market reaction Comment Full text

XBIOTECH INC. (XBIT)

  • Business News
  • June 15, 2026, 13:00 UTC
  • 0
  • 1 comments

XBiotech startet klinische Phase-II-Studie zur Bewertung von Vilamakitug bei der Behandlung der aktiven axialen Spondyloarthritis

Market reaction Comment Full text

JOHN WILEY & SONS, INC. (WLY)

  • Business News
  • June 15, 2026, 13:00 UTC
  • 0
  • 1 comments

Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain

Market reaction Comment Full text
  • Previous
  • 1095
  • 1096
  • 1097
  • 1098
  • 1099
  • Next

Search

News categories

  • Technical Exchange News(13595)
  • Event(6229)
  • SEC News(354872)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(194882)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin